Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India

Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India

AIM: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency. To control the spread, a mass vaccination program is initiated. Antibody titer after vaccination can be a better marker to monitor immunological resp...

Full description

Bibliographic Details
Main Authors: Mukesh Kumar, Richa Singh, Abhishek Kamendu, Amit Kumar Singh, Jyoti Sangwan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Health Sciences and Biomedical Research KLEU
Subjects:
2019 novel coronavirus
coronavirus disease 2019
novel coronavirus pneumonia
severe acute respiratory syndrome coronavirus 2
Online Access:http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2022;volume=15;issue=3;spage=256;epage=260;aulast=Kumar

Similar Items

Similar Items